Turn Therapeutics Inc (TTRX)
Turn Therapeutics Inc. is a NASDAQ-listed common stock issuer in the healthcare sector, focused on pharmaceuticals. The company develops therapies for diseases affecting the skin, nails, and eyes, and its delivery technology is designed to penetrate skin and nails while also supporting acute and chronic wound care applications. Turn Therapeutics says this platform is intended to help healthcare institutions manage a range of conditions, including wounds, broader skin disorders, and dermatoses, while also addressing antibiotic resistance concerns. The company was incorporated in 2015 and is based in Westlake Village, California. It was previously known as Global Health Solutions, Inc. before adopting the Turn Therapeutics Inc. name in September 2025.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TTRX
|
$5.45
|
-45.6% Downside
|
Overvalued
|
$26
|
159.5% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
September 2, 2026
|
-77.8x
|
48.8x
|
—
|
299.4 M
|
293.3 M
|
2.0%
|
36.4%
|
11.5
|
—
|
101.6%
|
